Table 1_Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neur

Yu-Ning Liu authored a 23.5 KB text document on figshare, last updated April 13, 2026. The document is a critical appraisal of preclinical evidence for paeoniflorin as a disease-modifying therapy for diabetic peripheral neuropathy. It reviews mechanisms of action, highlights key translational constraints like bioavailability and exposure challenges, and outlines priority next steps for research.

Use Cases

• Literature review synthesis based on the detailed appraisal of preclinical studies.
• Identifying research gaps in pharmacokinetics and nerve exposure based on the highlighted translational constraints.
• Planning integrated PK-PD studies based on the outlined priority next steps.
• Assessing drug-drug interaction potential for polypharmacy patients based on the safety narrative discussion.

Strengths

• Document is under a CC-BY-4.0 license, allowing for broad reuse.
• The description provides a detailed, structured review of mechanisms and translational challenges.

Limitations

• The dataset is a single 23.5 KB DOCX file, indicating a very limited scope.
• Row count and column-level documentation are unknown; data structure must be inferred from the text.
• The content is a review article, not a primary dataset of experimental measurements.

Provenance

Source

Yu-Ning Liu via figshare.

Collection Method

Authored review and analysis.

Time Range

Publication date is implied as 2026.

Freshness

Last updated 2026-04-13 05:47:18

Geography

null